Europe does not have one psychedelic law. This guide compares Portugal’s decriminalization model, the Netherlands’ mushroom and truffle distinction, and Switzerland’s exceptional medical and research licensing system.

Iboga is a Central African plant with deep traditional significance; ibogaine is one of its best-known alkaloids. This article reviews addiction and mental-health research, serious cardiac risks, and legal approaches in Canada, the United States, New Zealand and Brazil.

A current global guide to the difference between legalization, decriminalization, medical access and research access for psilocybin, LSD and MDMA, with examples from Australia, Switzerland, Portugal, the Netherlands, Canada and Brazil.

Ayahuasca is not simply another name for DMT. This article explains the traditional Amazonian preparation, its pharmacology, emerging mental-health research, major safety concerns and the very different legal approaches in Brazil, Peru and other countries.